Cartesian Therapeutics, Inc.RNACNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, modest growth trend.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-32.77M
Near historical average
Average (9y)
$-35.26M
Historical baseline
Range
High:$34.07M
Low:$-61.47M
CAGR
+3.7%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-32.77M | +36.2% |
| 2023 | $-51.37M | -56.5% |
| 2022 | $-32.83M | +46.6% |
| 2021 | $-61.47M | -280.4% |
| 2020 | $34.07M | +166.2% |
| 2019 | $-51.48M | +14.3% |
| 2018 | $-60.05M | -13.8% |
| 2017 | $-52.77M | -160.3% |
| 2016 | $-20.27M | +14.2% |
| 2015 | $-23.63M | - |